Drugs / Tacalcitol
Tacalcitol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT00670241 Comparator | Apr 2008 → Feb 2009 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Phase 3 | NCT00640822 Comparator | Feb 2008 → Jun 2009 | psoriasis | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tacalcitol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00640822 ↗ |
| Known as | 1.alpha.,24-dihydroxyvitamin d3 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105611 ↗ |
| Known as | Bonalfa | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105611 ↗ |
| Known as | Curatoderm | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105611 ↗ |
| Modality | Small molecule | — CHEMBL2105611 ↗ |
| Route | Topical | “Once daily application” NCT00670241 ↗ |